ImmuCell Statistics
NASDAQ: ICCCHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD
9.69-0.28 (-2.81%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
ImmuCell by the numbers
ImmuCell has a market capitalization of $88.0 million based on 9.08M shares outstanding. Its trailing P/E ratio is 138.4. The stock trades 4.9% below its 50-day average and 14.1% above its 200-day average.
Average daily trading volume is 23.16K shares, or about $224,469 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ICCC valuation vs. peer median
| Metric | ICCC | Peer median | Difference |
|---|---|---|---|
| Market cap | $88.01M | $6.30M | +1298% |
| Avg. volume | 23.16K | 191.68K | -88% |
Peer median across 8 companies: IMDX, BMRA, VNRX, CDIO, TRIB, QCLS, VRAX, NNNN.
Valuation
- Market cap
- $88.01M
- P/E (TTM)
- 138.43
- EPS (TTM)
- $0.07
- Shares outstanding
- 9.08M
Price and trading
- Previous close
- 9.97
- Open
- 9.96
- Day range
- 9.69 – 9.99
- 52-week range
- 4.52 – 12.10
- 52-week change
- +50.23%
- Beta
- —
- Volume
- 5.16K
- Average volume
- 23.16K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 13, 2026
Additional statistics
- Market Cap
- 88.01M
- Pe
- 138.43
- Forward Pe
- -88.09
- Eps
- 0.07
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 12.10
- Week52 Low
- 4.52
- Avg Volume
- 23,165.00
- Shares Outstanding
- 9.08M
- Ma50
- 10.19
- Ma200
- 8.49
- Earnings Date
- Aug 13, 2026
- Pct From52w High
- -19.92%
- Pct From52w Low
- 114.38%